Improving Cost-Effectiveness in the Health Care Sector in Iceland:
Health outcomes and the quality of health care in Iceland are very good by international comparison, while income-related health inequality appears to be smaller than in most other countries. However, the health-care system is costly and, according to OECD estimates, public expenditure on health and...
Gespeichert in:
1. Verfasser: | |
---|---|
Format: | Elektronisch E-Book |
Sprache: | English |
Veröffentlicht: |
Paris
OECD Publishing
2008
|
Schriftenreihe: | OECD Economics Department Working Papers
no.645 |
Schlagworte: | |
Online-Zugang: | Volltext |
Zusammenfassung: | Health outcomes and the quality of health care in Iceland are very good by international comparison, while income-related health inequality appears to be smaller than in most other countries. However, the health-care system is costly and, according to OECD estimates, public expenditure on health and long-term care could reach 15% of GDP by 2050 if no restraining measures are taken. This highlights the importance of raising cost-effectiveness and spending efficiency more generally. To this end, it would seem advisable to remove impediments to private provision and open up the health sector to competition. At the same time, the introduction of cost-sharing should be considered where it does not exist (as in hospitals), although concerns about equity need to be taken into account. This would relieve the burden on public finances, as would the introduction of spending ceilings, cost-efficiency analysis and activity-based funding arrangements. The high cost of pharmaceuticals should be reduced by promoting competition and the use of inexpensive generic drugs. |
Beschreibung: | 1 Online-Ressource (26 p.) 21 x 29.7cm. |
DOI: | 10.1787/235327525311 |
Internformat
MARC
LEADER | 00000cam a22000002 4500 | ||
---|---|---|---|
001 | ZDB-13-SOC-061277762 | ||
003 | DE-627-1 | ||
005 | 20231204121406.0 | ||
007 | cr uuu---uuuuu | ||
008 | 210204s2008 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1787/235327525311 |2 doi | |
035 | |a (DE-627-1)061277762 | ||
035 | |a (DE-599)KEP061277762 | ||
035 | |a (FR-PaOEC)235327525311 | ||
035 | |a (EBP)061277762 | ||
040 | |a DE-627 |b ger |c DE-627 |e rda | ||
041 | |a eng | ||
084 | |a C23 |2 jelc | ||
084 | |a O57 |2 jelc | ||
084 | |a I12 |2 jelc | ||
084 | |a H73 |2 jelc | ||
084 | |a H51 |2 jelc | ||
100 | 1 | |a Suppanz, Hannes |e VerfasserIn |4 aut | |
245 | 1 | 0 | |a Improving Cost-Effectiveness in the Health Care Sector in Iceland |c Hannes, Suppanz = Améliorer le rapport coût-efficacité dans le secteur de la santé en Islande / Hannes, Suppanz |
246 | 3 | 3 | |a Améliorer le rapport coût-efficacité dans le secteur de la santé en Islande |
264 | 1 | |a Paris |b OECD Publishing |c 2008 | |
300 | |a 1 Online-Ressource (26 p.) |c 21 x 29.7cm. | ||
336 | |a Text |b txt |2 rdacontent | ||
337 | |a Computermedien |b c |2 rdamedia | ||
338 | |a Online-Ressource |b cr |2 rdacarrier | ||
490 | 0 | |a OECD Economics Department Working Papers |v no.645 | |
520 | |a Health outcomes and the quality of health care in Iceland are very good by international comparison, while income-related health inequality appears to be smaller than in most other countries. However, the health-care system is costly and, according to OECD estimates, public expenditure on health and long-term care could reach 15% of GDP by 2050 if no restraining measures are taken. This highlights the importance of raising cost-effectiveness and spending efficiency more generally. To this end, it would seem advisable to remove impediments to private provision and open up the health sector to competition. At the same time, the introduction of cost-sharing should be considered where it does not exist (as in hospitals), although concerns about equity need to be taken into account. This would relieve the burden on public finances, as would the introduction of spending ceilings, cost-efficiency analysis and activity-based funding arrangements. The high cost of pharmaceuticals should be reduced by promoting competition and the use of inexpensive generic drugs. | ||
650 | 4 | |a Economics | |
650 | 4 | |a Iceland | |
856 | 4 | 0 | |l FWS01 |p ZDB-13-SOC |q FWS_PDA_SOC |u https://doi.org/10.1787/235327525311 |3 Volltext |
912 | |a ZDB-13-SOC | ||
912 | |a ZDB-13-SOC | ||
951 | |a BO | ||
912 | |a ZDB-13-SOC | ||
049 | |a DE-863 |
Datensatz im Suchindex
DE-BY-FWS_katkey | ZDB-13-SOC-061277762 |
---|---|
_version_ | 1816797338859995136 |
adam_text | |
any_adam_object | |
author | Suppanz, Hannes |
author_facet | Suppanz, Hannes |
author_role | aut |
author_sort | Suppanz, Hannes |
author_variant | h s hs |
building | Verbundindex |
bvnumber | localFWS |
collection | ZDB-13-SOC |
ctrlnum | (DE-627-1)061277762 (DE-599)KEP061277762 (FR-PaOEC)235327525311 (EBP)061277762 |
discipline | Wirtschaftswissenschaften |
doi_str_mv | 10.1787/235327525311 |
format | Electronic eBook |
fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>02468cam a22004212 4500</leader><controlfield tag="001">ZDB-13-SOC-061277762</controlfield><controlfield tag="003">DE-627-1</controlfield><controlfield tag="005">20231204121406.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">210204s2008 xx |||||o 00| ||eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1787/235327525311</subfield><subfield code="2">doi</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627-1)061277762</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)KEP061277762</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(FR-PaOEC)235327525311</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(EBP)061277762</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rda</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">C23</subfield><subfield code="2">jelc</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">O57</subfield><subfield code="2">jelc</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">I12</subfield><subfield code="2">jelc</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">H73</subfield><subfield code="2">jelc</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">H51</subfield><subfield code="2">jelc</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Suppanz, Hannes</subfield><subfield code="e">VerfasserIn</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Improving Cost-Effectiveness in the Health Care Sector in Iceland</subfield><subfield code="c">Hannes, Suppanz = Améliorer le rapport coût-efficacité dans le secteur de la santé en Islande / Hannes, Suppanz</subfield></datafield><datafield tag="246" ind1="3" ind2="3"><subfield code="a">Améliorer le rapport coût-efficacité dans le secteur de la santé en Islande</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Paris</subfield><subfield code="b">OECD Publishing</subfield><subfield code="c">2008</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">1 Online-Ressource (26 p.)</subfield><subfield code="c">21 x 29.7cm.</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">Text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">Computermedien</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">Online-Ressource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="490" ind1="0" ind2=" "><subfield code="a">OECD Economics Department Working Papers</subfield><subfield code="v">no.645</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Health outcomes and the quality of health care in Iceland are very good by international comparison, while income-related health inequality appears to be smaller than in most other countries. However, the health-care system is costly and, according to OECD estimates, public expenditure on health and long-term care could reach 15% of GDP by 2050 if no restraining measures are taken. This highlights the importance of raising cost-effectiveness and spending efficiency more generally. To this end, it would seem advisable to remove impediments to private provision and open up the health sector to competition. At the same time, the introduction of cost-sharing should be considered where it does not exist (as in hospitals), although concerns about equity need to be taken into account. This would relieve the burden on public finances, as would the introduction of spending ceilings, cost-efficiency analysis and activity-based funding arrangements. The high cost of pharmaceuticals should be reduced by promoting competition and the use of inexpensive generic drugs.</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Economics</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Iceland</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="l">FWS01</subfield><subfield code="p">ZDB-13-SOC</subfield><subfield code="q">FWS_PDA_SOC</subfield><subfield code="u">https://doi.org/10.1787/235327525311</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">ZDB-13-SOC</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">ZDB-13-SOC</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">BO</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">ZDB-13-SOC</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-863</subfield></datafield></record></collection> |
id | ZDB-13-SOC-061277762 |
illustrated | Not Illustrated |
indexdate | 2024-11-26T14:56:00Z |
institution | BVB |
language | English |
open_access_boolean | |
owner | DE-863 DE-BY-FWS |
owner_facet | DE-863 DE-BY-FWS |
physical | 1 Online-Ressource (26 p.) 21 x 29.7cm. |
psigel | ZDB-13-SOC |
publishDate | 2008 |
publishDateSearch | 2008 |
publishDateSort | 2008 |
publisher | OECD Publishing |
record_format | marc |
series2 | OECD Economics Department Working Papers |
spelling | Suppanz, Hannes VerfasserIn aut Improving Cost-Effectiveness in the Health Care Sector in Iceland Hannes, Suppanz = Améliorer le rapport coût-efficacité dans le secteur de la santé en Islande / Hannes, Suppanz Améliorer le rapport coût-efficacité dans le secteur de la santé en Islande Paris OECD Publishing 2008 1 Online-Ressource (26 p.) 21 x 29.7cm. Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier OECD Economics Department Working Papers no.645 Health outcomes and the quality of health care in Iceland are very good by international comparison, while income-related health inequality appears to be smaller than in most other countries. However, the health-care system is costly and, according to OECD estimates, public expenditure on health and long-term care could reach 15% of GDP by 2050 if no restraining measures are taken. This highlights the importance of raising cost-effectiveness and spending efficiency more generally. To this end, it would seem advisable to remove impediments to private provision and open up the health sector to competition. At the same time, the introduction of cost-sharing should be considered where it does not exist (as in hospitals), although concerns about equity need to be taken into account. This would relieve the burden on public finances, as would the introduction of spending ceilings, cost-efficiency analysis and activity-based funding arrangements. The high cost of pharmaceuticals should be reduced by promoting competition and the use of inexpensive generic drugs. Economics Iceland FWS01 ZDB-13-SOC FWS_PDA_SOC https://doi.org/10.1787/235327525311 Volltext |
spellingShingle | Suppanz, Hannes Improving Cost-Effectiveness in the Health Care Sector in Iceland Economics Iceland |
title | Improving Cost-Effectiveness in the Health Care Sector in Iceland |
title_alt | Améliorer le rapport coût-efficacité dans le secteur de la santé en Islande |
title_auth | Improving Cost-Effectiveness in the Health Care Sector in Iceland |
title_exact_search | Improving Cost-Effectiveness in the Health Care Sector in Iceland |
title_full | Improving Cost-Effectiveness in the Health Care Sector in Iceland Hannes, Suppanz = Améliorer le rapport coût-efficacité dans le secteur de la santé en Islande / Hannes, Suppanz |
title_fullStr | Improving Cost-Effectiveness in the Health Care Sector in Iceland Hannes, Suppanz = Améliorer le rapport coût-efficacité dans le secteur de la santé en Islande / Hannes, Suppanz |
title_full_unstemmed | Improving Cost-Effectiveness in the Health Care Sector in Iceland Hannes, Suppanz = Améliorer le rapport coût-efficacité dans le secteur de la santé en Islande / Hannes, Suppanz |
title_short | Improving Cost-Effectiveness in the Health Care Sector in Iceland |
title_sort | improving cost effectiveness in the health care sector in iceland |
topic | Economics Iceland |
topic_facet | Economics Iceland |
url | https://doi.org/10.1787/235327525311 |
work_keys_str_mv | AT suppanzhannes improvingcosteffectivenessinthehealthcaresectoriniceland AT suppanzhannes ameliorerlerapportcoutefficacitedanslesecteurdelasanteenislande |